BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

756 related articles for article (PubMed ID: 36770817)

  • 1. Transporter-Mediated Drug Delivery.
    Gyimesi G; Hediger MA
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a novel microscale thermophoresis ligand-binding assay for characterization of SLC solute carriers using oligopeptide transporter PepT1 (SLC15 family) as a model system.
    Clémençon B; Lüscher BP; Hediger MA
    J Pharmacol Toxicol Methods; 2018; 92():67-76. PubMed ID: 29580877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting SLC transporters: small molecules as modulators and therapeutic opportunities.
    Schlessinger A; Zatorski N; Hutchinson K; Colas C
    Trends Biochem Sci; 2023 Sep; 48(9):801-814. PubMed ID: 37355450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational exploration of fold atlas for human solute carrier proteins.
    Xie T; Chi X; Huang B; Ye F; Zhou Q; Huang J
    Structure; 2022 Sep; 30(9):1321-1330.e5. PubMed ID: 35700727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiating SLC transporter activity: Emerging drug discovery opportunities.
    Rives ML; Javitch JA; Wickenden AD
    Biochem Pharmacol; 2017 Jul; 135():1-11. PubMed ID: 28214518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression analysis of human solute carrier (SLC) family transporters in nasal mucosa and RPMI 2650 cells.
    Dolberg AM; Reichl S
    Eur J Pharm Sci; 2018 Oct; 123():277-294. PubMed ID: 30041030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease.
    Schumann T; König J; Henke C; Willmes DM; Bornstein SR; Jordan J; Fromm MF; Birkenfeld AL
    Pharmacol Rev; 2020 Jan; 72(1):343-379. PubMed ID: 31882442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Minireview: Usefulness of Transporter-Targeted Prodrugs in Enhancing Membrane Permeability.
    Murakami T
    J Pharm Sci; 2016 Sep; 105(9):2515-2526. PubMed ID: 27321236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Druggability of Solute Carriers.
    Wang WW; Gallo L; Jadhav A; Hawkins R; Parker CG
    J Med Chem; 2020 Apr; 63(8):3834-3867. PubMed ID: 31774679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy.
    Hushmandi K; Einollahi B; Saadat SH; Lee EHC; Farani MR; Okina E; Huh YS; Nabavi N; Salimimoghadam S; Kumar AP
    Mol Metab; 2024 Jun; 84():101952. PubMed ID: 38705513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug target.
    Balakrishnan A; Polli JE
    Mol Pharm; 2006; 3(3):223-30. PubMed ID: 16749855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A widespread role for SLC transmembrane transporters in resistance to cytotoxic drugs.
    Girardi E; César-Razquin A; Lindinger S; Papakostas K; Konecka J; Hemmerich J; Kickinger S; Kartnig F; Gürtl B; Klavins K; Sedlyarov V; Ingles-Prieto A; Fiume G; Koren A; Lardeau CH; Kumaran Kandasamy R; Kubicek S; Ecker GF; Superti-Furga G
    Nat Chem Biol; 2020 Apr; 16(4):469-478. PubMed ID: 32152546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Solute Carrier Transporters in Glioma Pathology: A Comprehensive Review.
    Anagnostakis F; Kokkorakis M; Markouli M; Piperi C
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane transporters in cell physiology, cancer metabolism and drug response.
    Alam S; Doherty E; Ortega-Prieto P; Arizanova J; Fets L
    Dis Model Mech; 2023 Nov; 16(11):. PubMed ID: 38037877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploiting Cysteine Residues of SLC Membrane Transporters as Targets for Drugs.
    Scalise M; Console L; Galluccio M; Pochini L; Tonazzi A; Giangregorio N; Indiveri C
    SLAS Discov; 2019 Oct; 24(9):867-881. PubMed ID: 31251685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A guide to plasma membrane solute carrier proteins.
    Pizzagalli MD; Bensimon A; Superti-Furga G
    FEBS J; 2021 May; 288(9):2784-2835. PubMed ID: 32810346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SLC transporter in nutrient and metabolic sensing, regulation, and drug development.
    Zhang Y; Zhang Y; Sun K; Meng Z; Chen L
    J Mol Cell Biol; 2019 Jan; 11(1):1-13. PubMed ID: 30239845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TICBase: Integrated Resource for Data on Drug and Environmental Chemical Interactions with Mammalian Drug Transporters.
    Michel ME; Wen CC; Yee SW; Giacomini KM; Hamdoun A; Nicklisch SCT
    Clin Pharmacol Ther; 2023 Dec; 114(6):1293-1303. PubMed ID: 37657924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting solute carriers to modulate receptor-ligand interactions.
    Sijben HJ; Superti-Furga G; IJzerman AP; Heitman LH
    Trends Pharmacol Sci; 2022 May; 43(5):358-361. PubMed ID: 35232590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harnessing Solute Carrier Transporters for Precision Oncology.
    Nyquist MD; Prasad B; Mostaghel EA
    Molecules; 2017 Mar; 22(4):. PubMed ID: 28350329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.